Written in Blood

Written in Blood

Research from recent issues of Blood

WIB_icon

Older Patients with iTTP Have Delayed Diagnosis and Higher Mortality Than Younger Counterparts

Older patients diagnosed with immune thrombotic thrombocytopenic purpura (iTTP) have worse short- and long-term mortality compared with younger patients and the general population, according...
WIB_icon

Eltrombopag Induces Complete Platelet Responses in Patients with Lymphoproliferative Disorders and Treatment-Resistant ITP

Results from a small phase II trial suggest that treatment with eltrombopag was associated with sustained platelet responses and complete responses (CRs) in patients...
WIB_icon

Study Identifies Familial Risk Patterns of Several Hematologic Malignancies

People who have a first-degree relative diagnosed with a hematologic malignancy have a higher risk of developing a blood cancer, according to an analysis...
WIB_icon

Pegylated Interferon Leads to High Response Rates in Essential Thrombocythemia and Polycythemia Vera After...

According to results of a phase II study published in Blood, treatment with pegylated-interferon-α (PEG-rIFN-α) was associated with an overall response rate (ORR) of...
WIB_icon

Estimated Prevalence of JAK2 V617F Mutations High in General Danish Population

The driver mutation JAK2 V617F and Calreticulin (CALR) mutations constitute major diagnostic criteria of myeloproliferative neoplasms (MPNs), and, while JAK2 V617F has been detected...
WIB_icon

Risk of Severe GVHD Lower With Post-Transplant Cyclophosphamide Than ATG in Mismatched Unrelated Donor...

Antithymocyte globulin (ATG) is considered standard graft-versus-host disease (GVHD) prophylaxis in patients with acute myeloid leukemia (AML) who undergo transplantation with a mismatched unrelated...
WIB_icon

Short, Aggressive Antibiotic Therapy Inhibits Lymphocyte Proliferation in CTCL

According to a study published in Blood, patients with advanced-stage cutaneous T cell lymphoma (CTCL) a short, yet aggressive, antibiotic regimen inhibited disease activity...
WIB_icon

Equal Access to Treatment Erases Difference in Outcomes Between White and African American Patients...

If African American patients with multiple myeloma (MM) are given equal access to treatments, they have outcomes that are as good as or better...
WIB_icon

Evaluating Safety and Efficacy of Venetoclax Plus R-CHOP in Non-Hodgkin Lymphoma

According to results from the phase Ib CAVALLI study, treatment with the oral BCL2 inhibitor venetoclax, combined with standard immunochemotherapy, induced high response rates...
WIB_icon

Study Finds Urgent Need for Sickle Cell Disease Screening Among African Refugees in Italy

Most refugees who arrive at the Mediterranean coast of Italy and other southern European countries are leaving areas where sickle cell disease (SCD) is...
Advertisement

Current Issue

November 2019 Bonus ASH Annual Meeting Preview Edition (Volume 5, Issue...

This issue offers an inside look at this year’s annual meeting, advice for giving effective presentations, and more.